Disclosures for "Solriamfetol Real World Experience Study: Initiation, Titration, Safety, Effectiveness, and Experience During Follow-Up for Patients with Narcolepsy from Germany")
-
Dr. Winter has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer AG. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bioprojet.
-
Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen, Idorsia, NLS Pharma. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia, Takeda. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Idorsia.
-
Dr. Kotterba has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Kotterba has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bioprojet. Dr. Kotterba has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Kotterba has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for biogen.
-
Heike Benes has nothing to disclose.
-
Lothar Burghaus has nothing to disclose.
-
Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
-
Dr. Koch has received personal compensation for serving as an employee of Jazz Pharmaceuticals Germany GmbH. Dr. Koch has stock in Jazz Pharmaceuticals.
-
Daniela Girfoglio has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Daniela Girfoglio has stock in Jazz Pharmaceuticals.
-
Ms. Setanoians has received personal compensation for serving as an employee of jazzpharmaceuticals. Ms. Setanoians has stock in jazzpharmaceuticals.
-
Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AOP Orphan . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioprojet . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AOP Orphan . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet . Prof. Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz . Prof. Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda . Prof. Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB .